follows: Unit: Million Baht Revenue Structure Q3/2019 Q3/2018 Change General Patient Revenue 1,683.8 1,518.9 164.9 10.9% Social Security Scheme Revenue 785.4 709.1 76.3 10.8% Other Revenue 31.3 26.3 5.0
the performance and the financial status for the year 2019 ended December 31, 2019 of the Company and its subsidiaries, as shown below: (Unit : Thousand Baht) 2019 2018 Change %Change Revenue 910,707
less land expenses and legal fee. Loss from change in fair value of biological assets : The subsidiary (UPOIC) realized loss from change in fair value of biological assets of Baht 4.6 million (Q1/2019
consolidated EBITDA in 1Q2020 was THB 751. 67 million, increased by THB 147.95 million or 24.51% up from 1Q2019. Financial Highlights 1Q 2020 1Q 2019 Change THB million % Sales THB million % Sales THB million
for rent and Baht 5.4 Million from gain on change in fair value less cost of sale of biological assets. Financial Cost Financial cost in Q2/2020 was Baht 8.1 Million had decreased by Baht 0.4 Million or
ทางการเงิน สำหรับงวดหกเดือนสิ้นสุดวันที่ 30 มิถุนายน 2563 และ 30 มิถุนายน 2562 ดังนี้: Q2 2563 Q2 2562 YoY change YoY % change หน่วย: ล้านบาท รายได้จากการขายและบริการ 232.44 229.27 3.17 1% รายได้อ่ืน 3.27
-20 % Change Amount % Amount % Amount % Q3-20 VS Q3-19 Q3-20 VS Q2-20 Sales revenue 17,540 100.0 12,404 100.0 14,491 100.0 41.4 21.0 Gross profit 4,574 26.1 2,373 19.1 3,892 26.9 92.8 17.5 Operating
% Change Amount % Amount % Amount % Q1-21 VS Q1-20 Q1-21 VS Q4-20 Sales revenue 19,039 100.0 12,755 100.0 18,498 100.0 49.3 2.9 Gross profit 4,103 21.6 2,586 20.3 4,067 22.0 58.7 0.9 Operating profit 1,372
Thailand Sustainability Investment 4/ Thailand Sustainability Investment n/a Ranking by Industry Business 4/ Market/Industry/Sector Change Effective Date 02/07/2015 Previous Market/Industry/Sector SET
ratio did not exceed 3.00 times, which is the covenant for bank loans and debentures. 3 Income Statement For the year ended December 31 Change Unit: Million Baht 2019 2018 Amount % Revenues from